Search Results 211-220 of 16090 for pharmacogenetics
The Department of Cancer Biology at Mayo Clinic is studying oncogenic gene dysregulation and carcinogenesis, including the cancer signaling process.
About this study. The purpose of this study is to evauate how well genetic testing works in guiding treatment for patients with solid tumors that have ...
About this study. A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to ...
The purpose of this study is to use a patient's own cells to fabricate a recellularized scaffold to repopulate the lung and restore function that could offer a ...
Learn about Dr. Nilufer Ertekin-Taner, her research, and faculty and staff in the Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
The purpose of this study is to identify the magnitude of variation among intensivists in use of diagnostic testing and to determine whether variation in ...
Cellular processes regulated by phosphoinositide signaling. Dr. Ling's lab seeks to define the role of phosphoinositide signaling in cell migration, ...
Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined with Tumor Treatment Fields (TTF) in Patients with Metastatic Pancreatic Adenocarcinoma.
Learn about a healthcare career as a molecular genetics technologist, what they do, where they work, and programs at Mayo Clinic College of Medicine and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.